A new perspective on NAFLD: Focusing on lipid droplets

E Scorletti, RM Carr - Journal of hepatology, 2022 - Elsevier
Lipid droplets (LDs) are complex and metabolically active organelles. They are composed of
a neutral lipid core surrounded by a monolayer of phospholipids and proteins. LD …

Liver fibrosis: therapeutic targets and advances in drug therapy

Z Tan, H Sun, T Xue, C Gan, H Liu, Y Xie… - Frontiers in cell and …, 2021 - frontiersin.org
Liver fibrosis is an abnormal wound repair response caused by a variety of chronic liver
injuries, which is characterized by over-deposition of diffuse extracellular matrix (ECM) and …

Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver

GH Goossens, JWE Jocken, EE Blaak - Nature Reviews Endocrinology, 2021 - nature.com
Obesity is associated with many adverse health effects, such as an increased
cardiometabolic risk. Despite higher adiposity for a given BMI, premenopausal women are at …

Diagnosis and management of non‐alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the S tudy G roup of L iver and M …

X Gao, JG Fan… - Journal of …, 2013 - Wiley Online Library
摘要非酒精性脂肪性肝病(Non‐alcoholic fatty liver disease, NAFLD) 是西方国家最常见的肝脏
疾病, 在普通人群中的患病率约为20%–33%. 我国已报道的研究数据显示 …

[PDF][PDF] The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

J Boursier, O Mueller, M Barret, M Machado… - …, 2016 - Wiley Online Library
Several animal studies have emphasized the role of gut microbiota in nonalcoholic fatty liver
disease (NAFLD). However, data about gut dysbiosis in human NAFLD remain scarce in the …

[HTML][HTML] Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

CY Zhang, WG Yuan, P He, JH Lei… - World journal of …, 2016 - ncbi.nlm.nih.gov
Liver fibrosis is a reversible wound-healing process aimed at maintaining organ integrity,
and presents as the critical pre-stage of liver cirrhosis, which will eventually progress to …

[HTML][HTML] Hepatic fibrosis: concept to treatment

C Trautwein, SL Friedman, D Schuppan, M Pinzani - Journal of hepatology, 2015 - Elsevier
Understanding the molecular mechanisms underlying liver fibrogenesis is fundamentally
relevant to developing new treatments that are independent of the underlying etiology. The …

Nonalcoholic fatty liver disease: pathogenesis and disease spectrum

T Hardy, F Oakley, QM Anstee… - Annual review of …, 2016 - annualreviews.org
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver dysfunction in
the Western world and is increasing owing to its close association with obesity and insulin …

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

QM Anstee, G Targher, CP Day - Nature reviews Gastroenterology & …, 2013 - nature.com
NAFLD is a spectrum of progressive liver disease that encompasses simple steatosis,
NASH, fibrosis and, ultimately, cirrhosis. NAFLD is recognized as the hepatic component of …

[HTML][HTML] Radiologic evaluation of nonalcoholic fatty liver disease

SS Lee, SH Park - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is a frequent cause of chronic liver diseases,
ranging from simple steatosis to nonalcoholic steatohepatitis (NASH)-related liver cirrhosis …